11-2130822-G-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000612.6(IGF2):c.*2165C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000089 ( 0 hom., cov: 14)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
IGF2
NM_000612.6 3_prime_UTR
NM_000612.6 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0770
Publications
17 publications found
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IGF2 | NM_000612.6 | c.*2165C>G | 3_prime_UTR_variant | Exon 4 of 4 | ENST00000416167.7 | NP_000603.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IGF2 | ENST00000416167.7 | c.*2165C>G | 3_prime_UTR_variant | Exon 4 of 4 | 1 | NM_000612.6 | ENSP00000414497.2 | |||
| IGF2 | ENST00000381406.8 | c.*2165C>G | 3_prime_UTR_variant | Exon 4 of 4 | 2 | ENSP00000370813.4 | ||||
| IGF2 | ENST00000381395.5 | c.*2165C>G | 3_prime_UTR_variant | Exon 4 of 4 | 2 | ENSP00000370802.1 |
Frequencies
GnomAD3 genomes AF: 0.0000893 AC: 6AN: 67214Hom.: 0 Cov.: 14 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
67214
Hom.:
Cov.:
14
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 8248Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 3914
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
8248
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
3914
African (AFR)
AF:
AC:
0
AN:
252
American (AMR)
AF:
AC:
0
AN:
164
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
484
East Asian (EAS)
AF:
AC:
0
AN:
3024
South Asian (SAS)
AF:
AC:
0
AN:
44
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AF:
AC:
0
AN:
42
European-Non Finnish (NFE)
AF:
AC:
0
AN:
3704
Other (OTH)
AF:
AC:
0
AN:
532
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000892 AC: 6AN: 67252Hom.: 0 Cov.: 14 AF XY: 0.0000622 AC XY: 2AN XY: 32174 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
6
AN:
67252
Hom.:
Cov.:
14
AF XY:
AC XY:
2
AN XY:
32174
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
4
AN:
17430
American (AMR)
AF:
AC:
0
AN:
5174
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1872
East Asian (EAS)
AF:
AC:
0
AN:
2638
South Asian (SAS)
AF:
AC:
1
AN:
1818
European-Finnish (FIN)
AF:
AC:
0
AN:
3354
Middle Eastern (MID)
AF:
AC:
0
AN:
116
European-Non Finnish (NFE)
AF:
AC:
1
AN:
33556
Other (OTH)
AF:
AC:
0
AN:
886
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000412196), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.